Listen: Indianapolis Is Using The Amazon HQ2 To Revitalize Downtown

 

The recent competition for the location of Amazon’s HQ2 has really generated a lot of buzz nationwide as many cities look to submit their best qualities as to why they should be considered. Of course, places like Denver, Chicago, New York City, Dallas, and even Austin have proved themselves to be top contenders but to the surprise of many is rise of this city: Indianapolis.

Some may still be puzzled as to why Indianapolis was to make the list but for residents, it’s clear that the whole city has diversifying for quite some time not only building a reputable transit and park infrastructure, but also creating its very own tech scene. All of this is occurring while still maintaining a high level of affordability. With all this to consider, the city still faces its own set of challenges as they still seek to achieve broad-based prosperity. Bill Taft, Executive Director of the Indianapolis Local Initiatives Support Corporation recently said that, “We have a civic culture that’s really good at taking on and accomplishing big, common goals.”

So, don’t write off Indianapolis as they’ve truly proved themselves to be quite the competitor when it comes to Amazon making their final decision on their next Headquarter location.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More